On Tuesday, Enlivex Therapeutics Ltd (NASDAQ: ENLV) opened lower -9.79% from the last session, before settling in for the closing price of $0.74. Price fluctuations for ENLV have ranged from $0.73 to $2.10 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 7.57% over the past five years. Company’s average yearly earnings per share was noted 10.64% at the time writing. With a float of $23.17 million, this company’s outstanding shares have now reached $24.29 million.
Enlivex Therapeutics Ltd (ENLV) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Enlivex Therapeutics Ltd is 4.61%, while institutional ownership is 4.41%.
Enlivex Therapeutics Ltd (ENLV) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.23 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.16) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 10.64% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.46% during the next five years compared to 7.57% growth over the previous five years of trading.
Enlivex Therapeutics Ltd (NASDAQ: ENLV) Trading Performance Indicators
Check out the current performance indicators for Enlivex Therapeutics Ltd (ENLV). In the past quarter, the stock posted a quick ratio of 6.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.53, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.59 in one year’s time.
Technical Analysis of Enlivex Therapeutics Ltd (ENLV)
Enlivex Therapeutics Ltd (NASDAQ: ENLV) saw its 5-day average volume 0.5 million, a negative change from its year-to-date volume of 1.16 million. As of the previous 9 days, the stock’s Stochastic %D was 6.68%.
During the past 100 days, Enlivex Therapeutics Ltd’s (ENLV) raw stochastic average was set at 0.35%, which indicates a significant decrease from 1.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0703 in the past 14 days, which was lower than the 0.0827 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9693, while its 200-day Moving Average is $1.0643. Nevertheless, the first resistance level for the watch stands at $0.7063 in the near term. At $0.7407, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.7603. If the price goes on to break the first support level at $0.6523, it is likely to go to the next support level at $0.6327. The third support level lies at $0.5983 if the price breaches the second support level.
Enlivex Therapeutics Ltd (NASDAQ: ENLV) Key Stats
There are currently 24,293K shares outstanding in the company with a market cap of 16.33 million. Presently, the company’s annual sales total 0 K according to its annual income of -15,010 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -2,210 K.
